Vident Advisory »

Intellia Therapeutics shares owned by Vident Advisory

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Vident Advisory from 13F filings

Historical chart of Vident Advisory investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Vident Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Vident Advisory

Quarter filed Position value Share count Share price at filing
2023-12-31 $502k 17k 30.49
2023-09-30 $499k 16k 31.62